Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Japanese approval for Modiodal in narcolepsy

Jan. 30, 2007

Valeant develops intranasal diazepam for seizure emergencies

Jan. 30, 2007

Michael J. Fox Foundation funds industry development efforts in Parkinson's

Jan. 30, 2007

Antiparkinsonian effects of S-32504 via D2 receptors are not associated with significant dyskinesia

Jan. 29, 2007

Preclinical characterization of SLV-313, a novel D2 receptor antagonist/5-HT1A receptor agonist

Jan. 29, 2007

Barrow receives grant to support neurofibromatosis research

Jan. 26, 2007

New trial evaluates oral cladribine with Rebif for MS

Jan. 26, 2007

Intranasal insulin improves memory

Jan. 26, 2007

Preclinical characterization of SSR-180711, a novel selective alpha7 nAChRr partial agonist

Jan. 26, 2007

NNZ-2566 is safe in phase I study

Jan. 26, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...